Acorda Therapeutics Inc (ACORQ)
0.605
+0.10
(+18.63%)
USD |
OTCM |
May 17, 16:00
Acorda Therapeutics Profit Margin (Quarterly): -135.0% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -135.0% |
| December 31, 2023 | -573.3% |
| September 30, 2023 | -32.07% |
| June 30, 2023 | -31.61% |
| March 31, 2023 | -75.59% |
| December 31, 2022 | 60.83% |
| September 30, 2022 | -41.34% |
| June 30, 2022 | -150.3% |
| March 31, 2022 | -108.8% |
| December 31, 2021 | -55.64% |
| September 30, 2021 | -86.06% |
| June 30, 2021 | -71.93% |
| March 31, 2021 | -115.9% |
| December 31, 2020 | -217.6% |
| September 30, 2020 | 13.84% |
| June 30, 2020 | -51.82% |
| March 31, 2020 | -23.03% |
| December 31, 2019 | |
| September 30, 2019 | -552.2% |
| June 30, 2019 | -54.91% |
| March 31, 2019 | -107.9% |
| December 31, 2018 | 13.88% |
| September 30, 2018 | -9.74% |
| June 30, 2018 | 30.13% |
| March 31, 2018 | -7.72% |
| Date | Value |
|---|---|
| December 31, 2017 | -90.28% |
| September 30, 2017 | -17.86% |
| June 30, 2017 | -5.88% |
| March 31, 2017 | -15.83% |
| December 31, 2016 | -2.20% |
| September 30, 2016 | -9.38% |
| June 30, 2016 | -14.34% |
| March 31, 2016 | -0.45% |
| December 31, 2015 | 7.03% |
| September 30, 2015 | 2.66% |
| June 30, 2015 | 0.88% |
| March 31, 2015 | -3.09% |
| December 31, 2014 | 0.28% |
| September 30, 2014 | 11.28% |
| June 30, 2014 | 4.82% |
| March 31, 2014 | 0.87% |
| December 31, 2013 | 6.69% |
| September 30, 2013 | 8.80% |
| June 30, 2013 | 4.49% |
| March 31, 2013 | -1.58% |
| December 31, 2012 | |
| September 30, 2012 | 12.39% |
| June 30, 2012 | 6.01% |
| March 31, 2012 | 11.01% |
| December 31, 2011 | 17.47% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-573.3%
Minimum
Dec 2023
60.83%
Maximum
Dec 2022
-121.2%
Average
-71.93%
Median
Jun 2021
Profit Margin (Quarterly) Benchmarks
| BioSig Technologies Inc | -50.41K% |
| Verve Therapeutics Inc | -855.8% |
| Spectral AI Inc | -309.0% |
| AIM ImmunoTech Inc | -19.35K% |
| Protalix BioTherapeutics Inc | -122.6% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -101.6% |
| Return on Invested Capital | -171.9% |
| Gross Profit Margin (Quarterly) | 81.73% |
| Operating Margin (Quarterly) | -65.98% |
| Return on Net Operating Assets | -117.9% |